Robert M. Rakita

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Acute Hepatitis A Viral Infection in People With HIV With Previously Documented Hepatitis A Immunity or Appropriate Vaccination: A Case Series”.

Acute Hepatitis A Viral Infection in People With HIV With Previously Documented Hepatitis A Immunity or Appropriate Vaccination: A Case Series

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab347

N/A

0.241DataRank · unranked

4 citations

Jason D. Simmons, Hilary F. Armstrong, Elysia Gonzales, Robert M. Rakita, Jeffrey S. Duchin +2 more

Delayed Mortality Among Solid Organ Transplant Recipients Hospitalized for COVID-19

Clinical Infectious Diseases(2022)10.1093/cid/ciac159

N/A

0DataRank · unranked

15 citations

Olivia S. Kates, Kassem Safa, Camille N. Kotton, Ashrit Multani, Sarah J. Georgia +94 more

Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic

American Journal of Transplantation(2021)10.1111/ajt.16840

N/A

0DataRank · unranked

79 citations

Olivia S. Kates, Kassem Safa, Camille N. Kotton, Sarah J. Georgia, Julie M. Steinbrink +39 more

Real‐world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high‐risk donor seropositive/recipient seronegative (D+R‐) liver transplant recipients (LTxR)

Transplant Infectious Disease(2023)10.1111/tid.14015

N/A

0DataRank · unranked

13 citations

Catherine E. Kling, Madeleine R. Heldman, Nina Singh, Marilyn M. Wagener, Robert M. Rakita +3 more

A practical guide to real‐world implementation of pre‐emptive therapy for Cytomegalovirus disease prevention in high‐risk seronegative liver transplant recipients with seropositive donors

Transplant Infectious Disease(2024)10.1111/tid.14229

N/A

0DataRank · unranked

3 citations

Bailey Dunn, Evan Clemens, Megan Henderson, Cynthia E. Fisher, Robert M. Rakita +3 more

Response to Yates and Halliday Regarding Cytomegalovirus (CMV) DNAemia and Time to Death in a Randomized Trial of Preemptive Therapy Versus Antiviral Prophylaxis in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients

Clinical Infectious Diseases(2024)10.1093/cid/ciae005

N/A

0DataRank · unranked

0 citations

Sayan Dasgupta, Cristina Murray‐Krezan, Nina Singh, Robert M. Rakita, Cynthia E. Fisher +2 more

Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients

Clinical Infectious Diseases(2023)10.1093/cid/ciad643

N/A

0DataRank · unranked

17 citations

Sayan Dasgupta, Cristina Murray‐Krezan, Nina Singh, Robert M. Rakita, Cynthia E. Fisher +2 more